These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8819244)

  • 1. Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants.
    van der Meer FJ; Rosendaal FR; Vandenbroucke JP; Briët E
    Thromb Haemost; 1996 Jul; 76(1):12-6. PubMed ID: 8819244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V; Legnani C; Noventa F; Palareti G;
    Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.
    Pelicano N; Branco LM; Pinto A; Sá A; Timóteo AT; Feliciano J; Fiarresga A; Agapito AF; Palma MC; Quininha J
    Rev Port Cardiol; 2005; 24(7-8):957-68. PubMed ID: 16240682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemorrhagic complications in patients treated with oral anticoagulants].
    Amian A; Rodríguez JN; Diéguez JC; Cañavate M; Fernández A; Martino ML; Muñiz R; Prados D
    Sangre (Barc); 1993 Oct; 38(5):349-53. PubMed ID: 8140495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
    Abdelhafiz AH; Wheeldon NM
    Am J Geriatr Pharmacother; 2008 Mar; 6(1):1-11. PubMed ID: 18396243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.
    Palareti G; Legnani C; Lee A; Manotti C; Hirsh J; D'Angelo A; Pengo V; Moia M; Coccheri S
    Thromb Haemost; 2000 Nov; 84(5):805-10. PubMed ID: 11127860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH; Wheeldon NM
    Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
    Watzke HH; Forberg E; Svolba G; Jimenez-Boj E; Krinninger B
    Thromb Haemost; 2000 May; 83(5):661-5. PubMed ID: 10823258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors.
    Hylek EM
    Semin Vasc Med; 2003 Aug; 3(3):271-8. PubMed ID: 15199460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorrhagic complications and thrombotic phenomena in oral anticoagulation of elderly patients].
    Selva O'Callaghan A; San José Laporte A; Fuentes Camps I; Nicolau Fuste J; Piqueras Carrasco J; Vilardell Tarres M
    Rev Clin Esp; 1997 May; 197(5):323-8. PubMed ID: 9280965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
    Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' perceptions regarding oral anticoagulation therapy and its effect on quality of life.
    Casais P; Meschengieser SS; Sanchez-Luceros A; Lazzari MA
    Curr Med Res Opin; 2005 Jul; 21(7):1085-90. PubMed ID: 16004677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real-practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Boddi V; Gensini GF; Abbate R; Prisco D
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):269-75. PubMed ID: 12695750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
    Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
    Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.